Korea Pharmacy Co. Ltd.

032300 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

7,460.00KRW-220.00 (-2.86%)

Price History

Full chart

Market Stats

Previous Close7,680.00

Open7,680.00

Day Range7,460.00 – 7,880.00

52-Week Range6,350.00 – 14,950.00

Volume11.61K

Market Cap81.80B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.68%

Beta0.72

50-Day Avg7,622.00

200-Day Avg10,310.20

About

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Eun-Hee Park
Employees0
Headquarters14, Teheran-ro 4-gil, Seoul, South Korea, 06232, Korea
Websitehttps://www.koreapharma.co.kr

Leadership

Ms. Eun-Hee ParkCEO & Director · b. 1957
Mr. Yong-Ki ParkChief Financial Officer · b. 1961

Financials

Income Statement

Currency: KRW	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	60.48B	66.14B	71.51B	79.58B	81.03B	83.24B	81.28B	87.60B
Growth (%)	-	+9.34%	+8.12%	+11.28%	+1.83%	+2.73%	-2.36%	+7.78%
Cost of Revenue	32.39B	33.01B	37.35B	43.67B	45.60B	46.32B	46.10B	56.20B
Gross Profit	28.10B	33.12B	34.16B	35.90B	35.43B	36.92B	35.17B	31.40B
Gross Margin	46.45%	50.08%	47.77%	45.12%	43.72%	44.36%	43.28%	35.85%
Operating Expense	23.04B	26.78B	29.55B	30.89B	29.24B	32.98B	27.61B	32.29B
Operating Income	5.05B	6.35B	4.60B	5.01B	6.19B	3.94B	7.56B	-887.33M
Operating Margin	8.35%	9.59%	6.44%	6.30%	7.64%	4.73%	9.30%	-1.01%
EBITDA	-	-	-	-	4.47B	8.57B	9.58B	2.21B
EBITDA Margin	-	-	-	-	5.51%	10.29%	11.79%	2.52%
Net Income	3.83B	5.53B	3.16B	6.37B	-1.12B	83.76M	3.79B	-2.64B
Net Income Margin	6.33%	8.36%	4.42%	8.00%	-1.38%	0.10%	4.67%	-3.01%
R&D	-	3.70B	6.22B	4.89B	2.45B	2.31B	2.05B	2.43B
R&D as % of Total Revenue	-	5.60%	8.70%	6.15%	3.03%	2.78%	2.53%	2.78%
Interest Expense	0	582.29M	435.67M	908.17M	3.87B	3.74B	2.88B	3.57B
Interest Expense % of Total Revenue	0.00%	0.88%	0.61%	1.14%	4.77%	4.49%	3.54%	4.07%

Balance Sheet

Currency: KRW	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	62.23B	66.75B	81.32B	129.40B	130.95B	121.30B	112.39B	126.64B
Total Liabilities	39.99B	40.15B	34.82B	71.93B	71.13B	52.72B	40.95B	57.85B
Total Equity	22.24B	26.60B	46.50B	57.47B	59.82B	68.58B	71.44B	68.79B
Cash	16.77M	4.12M	16.86B	56.54B	8.39B	41.42B	21.91B	27.53B
Total Debt	18.06B	10.91B	10.05B	-	-	-	-	-
Net Debt	-	5.92B	-	-	44.94B	-	633.31M	10.06B

Cash Flow

Currency: KRW	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	4.88B	0	-873.84M	7.19B	8.28B	4.82B	8.05B	2.69B
Investing Cash Flow	-1.86B	0	-4.71B	-12.91B	-51.88B	44.90B	-12.34B	-
Financing Cash Flow	-104.98M	0	12.01B	45.36B	-4.56B	-16.66B	-15.30B	-
Capital Expenditure	1.73B	2.18B	1.97B	2.55B	2.46B	2.68B	3.80B	1.33B
Free Cash Flow	-	-	-3.52B	3.74B	5.53B	2.14B	4.24B	1.35B
Dividends Paid	-	-	439.27M	545.34M	545.34M	545.34M	545.34M	545.34M
FCF to OCF	-	-	402.59%	52.03%	66.76%	44.46%	52.75%	50.42%
Dividend Paid to FCF	-	-	-12.49%	14.57%	9.87%	25.45%	12.85%	40.26%

Earnings

Report Date	Sep 30, 2020	Dec 31, 2020	May 14, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023	Aug 11, 2023	Nov 13, 2023	Mar 19, 2024	May 14, 2024	Aug 13, 2024	Nov 11, 2024	Mar 17, 2025	May 14, 2025	Aug 11, 2025	Nov 12, 2025	Mar 18, 2026	May 12, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	87.32	47.56	90.31	238.22	134.89	125.12	50.08	85.80	59.45	-297.93	6.71	-46.02	114.44	-67.44	120.72	106.86	114.92	5.15	47.19	-34.45	-1.92	-252.91	62.57	121.33
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap81.80B

Enterprise Value84.52B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.87

Price / Book1.07

Revenue (TTM)93.94B

Gross Profit (TTM)33.64B

EBITDA4.75B

Profit Margin-0.82%

Operating Margin8.36%

Return on Equity-1.07%

Return on Assets0.81%

Shares Outstanding10.91M

Shares Float3.99M

Beta0.72

Dividend Yield0.68%

Dividend Rate50.00

Payout Ratio312.50%

Dividends

20251×

50.00Dec 29, 2025

20241×

50.00Dec 27, 2024

20231×

50.00Dec 27, 2023

20221×

50.00Dec 28, 2022

20211×

50.00Dec 29, 2021

20201×

50.00Dec 29, 2020